Search - tctmd.com

Displaying 541 - 552 of 552

Sort: Relevancy | Date

News Industry News

In New Cardiac Surgery Study NephroCheck® Kidney Biomarkers Rise To The Occasion

May 29, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Industry News

New Partnership Between St. Jude Medical and Mended Little Hearts Benefits Families of Kids with Congenital Heart Defects

April 27, 2015

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

October 30, 2013

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Daily News

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Yael L. Maxwell

July 10, 2012

News Daily News

Endovascular Treatment Costs High for Acute Stroke

Jason Kahn

October 13, 2011

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

Advertisement

In New Cardiac Surgery Study NephroCheck® Kidney Biomarkers Rise To The Occasion

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

New Partnership Between St. Jude Medical and Mended Little Hearts Benefits Families of Kids with Congenital Heart Defects

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

Innovation in Intervention: Perspectives from Industry

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Endovascular Treatment Costs High for Acute Stroke

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content